David Hung, Nuvation Bio CEO
Nuvation inks all-stock deal for US-China oncology biotech AnHeart
Nuvation Bio plans to buy AnHeart Therapeutics in an all-stock deal, the cancer drug developers said Monday morning, in a move …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
